| Geauga Rehabilitation Engineering | |
| 8401 Mentor Ave, Ste C, Mentor, Ohio 44060 | |
| (440) 266-0250 |
| Name | Geauga Rehabilitation Engineering |
|---|---|
| Organization Name | Geauga Rehabilitation Engineering, Inc. |
| Location | 8401 Mentor Ave, Ste C, Mentor, Ohio 44060 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (440) 266-0250 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The latest C.S. Mott Children's Hospital National Poll on Children's Health from the University of Michigan finds that few parents (10 percent) believe their own teens, ages 13 to 17 years old, have used alcohol in the last year and even fewer (5 percent) believe their own teens have used marijuana in the last year.
The use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) is widespread to reduce the pain associated with osteoarthritis; however the sideeffects of these drugs can be severe, sometimes leading to gastro-intestinal ulcer complications which account for around 7000 US and 1000 UK deaths each year.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar. Hospira obtained U.S. Food and Drug Administration approval of paricalcitol on Oct. 21 and launched the product Nov. 1.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
› Verified 3 days ago
| NPI Number | 1396708848 |
| Organization Name | GEAUGA REHABILITATION ENGINEERING, INC. |
| Type | Prosthetic/Orthotic Supplier |
| Address | 8401 Mentor Ave, Suite C, Mentor, OH 44060 |
| Phone Number | 440-266-0250 |
News Archive
The latest C.S. Mott Children's Hospital National Poll on Children's Health from the University of Michigan finds that few parents (10 percent) believe their own teens, ages 13 to 17 years old, have used alcohol in the last year and even fewer (5 percent) believe their own teens have used marijuana in the last year.
The use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) is widespread to reduce the pain associated with osteoarthritis; however the sideeffects of these drugs can be severe, sometimes leading to gastro-intestinal ulcer complications which account for around 7000 US and 1000 UK deaths each year.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar. Hospira obtained U.S. Food and Drug Administration approval of paricalcitol on Oct. 21 and launched the product Nov. 1.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
› Verified 3 days ago
News Archive
The latest C.S. Mott Children's Hospital National Poll on Children's Health from the University of Michigan finds that few parents (10 percent) believe their own teens, ages 13 to 17 years old, have used alcohol in the last year and even fewer (5 percent) believe their own teens have used marijuana in the last year.
The use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) is widespread to reduce the pain associated with osteoarthritis; however the sideeffects of these drugs can be severe, sometimes leading to gastro-intestinal ulcer complications which account for around 7000 US and 1000 UK deaths each year.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar. Hospira obtained U.S. Food and Drug Administration approval of paricalcitol on Oct. 21 and launched the product Nov. 1.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
› Verified 3 days ago
Cvs Pharmacy # 03326 Type: Community/Retail Pharmacy Location: 9040 Mentor Avenue, Mentor, Ohio 44060 Phone: (440) 255-9159 | |
Cvs Pharmacy # 07686 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7301 Lakeshore Blvd, Mentor, Ohio 44060 Phone: (440) 602-6071 | |
Rite Aid Pharmacy 03174 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7796 Munson Rd, Mentor, Ohio 44060 Phone: (440) 257-6258 | |
Cvs Pharmacy #17388 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9669 Mentor Ave, Mentor, Ohio 44060 Phone: (440) 210-5054 | |
Walgreens #4317 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9400 Mentor Ave, Mentor, Ohio 44060 Phone: (440) 255-6247 |